Sidera Bio secures DKK 700 million in a Series A biotech round with Novo Holdings, Forbion, RA Capital Healthcare Fund LP, and Gilde Healthcare.
19 November 2025
19 November 2025
Total investments received (USD): 108.5M
Round value (USD): 108.5M
Company: Sidera Bio
Industry: BiotechHealth services
Related deals
Hemab raised $157m Series C led by Sofinnova, joined by Avoro Capital, RA Capital, Novo, Access Biotechnology, Deep Track, HealthCap, Invus, Maj Invest
Investments
16 October 2025
Belgium
Austria
Germany
Switzerland
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Ireland
Italy
Portugal
Spain
United Kingdom